Cervical mucus concentration of prostaglandins E2 and F2α after pretreatment with mifepristone in the first trimester of pregnancy
Autor: | Hans Bokström, Nils Wiqvist, Anders Norström |
---|---|
Rok vydání: | 1995 |
Předmět: |
Adult
medicine.medical_specialty Time Factors medicine.medical_treatment Chlamydia trachomatis Gestational Age Endogeny Cervix Uteri Dinoprost Biochemistry Dinoprostone Dilatation and Curettage Endocrinology Pregnancy Internal medicine medicine Humans Vacuum aspiration business.industry Nausea Radioimmunoassay Vaginosis Bacterial Mifepristone Chlamydia Infections medicine.disease Cervical mucus Pregnancy Trimester First Abortion Legal Cervix Mucus Gestation Female business Prostaglandin E medicine.drug |
Zdroj: | Prostaglandins. 49:41-48 |
ISSN: | 0090-6980 |
DOI: | 10.1016/0090-6980(94)00007-j |
Popis: | Cervical dilatation and softening after pretreatment with mifepristone are well documented. As this effect is similar to that observed after local application of prostaglandin E 2 (PGE 2 ) it is tempting to speculate that the effect of mifepristone is mediated via an increase of the endogenous secretion of prostaglandins from the cervical mucosa. Eighteen healthy women in the first trimester of pregnancy were treated with oral mifepristone (200 mg) 48 and 24 hours before legal abortion by vacuum aspiration and 18 women in the same age of gestation without any pretreatment served as controls. Cervical mucus was collected for measurement of prostaglandins by radioimmunoassay before administration of the drug and in connection with vacuum aspiration. The cervical dilatation at the time of surgery was significantly increased in women given mifepristone as compared with untreated women (7.6 versus 5.8 mm). The wet weight of collected cervical mucus was significantly increased in mifepristone treated women. The amount of PGE 2 and prostaglandin F 2α per sample was unchanged in mifepristone-treated women, whereas the concentration was lower as an effect of dilution due to an increased yield in cervical secretion observed after mifepristone treatment. The present observation does not give any support to the hypothesis that mifepristone-induced cervical maturation is mediated via an increase in cervical prostaglandin production. |
Databáze: | OpenAIRE |
Externí odkaz: |